Skip to content

Daniel Ruiqi Wang, MD

NPI 1174150072ActiveIndividual· Internal Medicine, Cardiovascular Disease· Pasadena, CA

Internal Medicine, Cardiovascular Disease (MD) in Pasadena, California, licensed in CA, with an NPI issued in March 2020. Part D covered 117 prescriptions written in 2024, 80% of them generic. Abbott Laboratories reported $75.75 in payments in 2025, mostly food and beverage.

Overview

NPI1174150072
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 23, 2020
Last updated in NPPESSep 18, 2026
Certified by providerSep 18, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Cardiovascular Disease (Cardiology) (CA)

Part D prescriptions in 2024

Prescriptions (claims)117 · 274 30-day fills
Patients21
Total drug cost$14,637
Generic share80% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$75.75 · 3 payments from 1 company
  • 2024$146.09 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Abbott Laboratories$75.753

What the 2025 payments were for

  • Food and Beverage$75.75 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other cardiologists in Pasadena

All 30 cardiologists in Pasadena · All cardiologists in California